Wednesday, November 8, 2017

Congress Weighs Repeal of Tax Credit for Rare Disease Drugs by KATIE THOMAS and SHEILA KAPLAN


By KATIE THOMAS and SHEILA KAPLAN

Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul.

Published: November 7, 2017 at 07:00PM

from NYT Health http://ift.tt/2zpkko8
via IFTTT




from WordPress http://ift.tt/2hVqWk9
via IFTTT

No comments:

Post a Comment